Professional Documents
Culture Documents
Nephrotic Syndrome Nephrotic Syndrome: Child Health II Child Health II
Nephrotic Syndrome Nephrotic Syndrome: Child Health II Child Health II
Nephrotic Syndrome Nephrotic Syndrome: Child Health II Child Health II
Nephrotic
Syndrome
Speaker : Shriyans
Definition
Manifestation of glomerular
disease, characterized by nephrotic
range proteinuria and a triad of
clinical findings associated with large
urinary losses of protein :
hypoalbuminaemia , edema and
hyperlipidemia
Incidence
( paediatric ) ?
2 7 cases per 100,000 children per
year
Higher in underdeveloped countries (
South east Asia )
Occurs at all ages but is most
prevalent in children between the
ages 1.5-6 years.
It affects more boys than girls, 2:1
http://www.kidney.org/site/107/pdf/NephroticSyndrome.pdf
Etiology
Genetic
Secondary
Idiopathic or Primary
Genetic causes
Secondary causes
Congenital
Oligomeganephronia
Infectious
Hepatitis (B,C) , HIV-1, Malaria, Syphilis, Toxoplasmosis
Inflammatory
Glomerulonephritis
Immunological
Castleman Disease, Kimura Disease, Bee sting, Food allergens
Neoplastic
Lymphoma, Leukemia
Idiopathic
Pathophysiology
http://www.highlands.edu/academics/divisions/scipe/biology/faculty/harnden/2122/images/renalcorpuscle.jpg
Complex disturbances in
immune system
Genetic Mutations /
Mutations in proteins
Clinical Features
Edema
Mild to start with peri orbital puffiness, lower
extremities
Progression to generalized edema, ascites,
pleural effusion, genital edema
CLINICAL
FEATURES
Minimal Change
Nephrotic
Syndrome
Focal
Segmental
Glomeruloscle
rosis
Membrano
us
Nephropat
hy
Age ( yr )
2- 6
2 - 10
40 - 50
Sex ( M : F )
2:1
1.3 : 1
2:1
Nephrotic
Syndrome
100 %
90 %
80 %
Asymptomatic
proteinuria
10 %
20 %
Hematuria
10 20 %
60 80 %
60 %
Hypertension
10 %
20 % early
infrequent
Rate of
progression to
renal failure
Non progressive
10 yrs
50 % in 10
20 yrs
Associated
Conditions
Usually none
None
Renal vein
thrombosis,
SLE,
Hepatitis B
DIFFERENTIALS
Lab Investigations
Urine Examination
Complete Blood Count & Blood picture
Renal parameters :
Spot Urine Protein : Creatinine ratio
Urinary protein excretion
protein selectivity ratio
Urinalysis - 3+ to 4+ proteinuria
Renal Function
Spot UPC ratio > 2.0
UPE > 40 mg/m2/hr
Serum Creatinine normal or elevated
Serum albumin - < 2.5 gm/dl
Serum Cholesterol/ TGA levels
elevated
Serum Complement levels Normal or
low
Additional Tests
C3 and antistreptolysin O
Chest X ray and tuberculin test
ANA
Hepatitis B surface antigen
Idiopathic
Lab Findings
Raised BUN in 15 30 %
Highly Selective
proteinuria
Focal Segmental
Glomerulosclerosis
Raised BUN in 20 40 %
Membranous Nephropathy
Membranoproliferative
Glomerulonephritis
Type I
Low C1, C4 , C3 C9
Type II
Cause
Light
microsco
py
Immunofloresc
ence
Electron
Microscopy
Minimal
Change
Nephrotic
Syndrome
Normal
Negative
Focal
Segmental
Glomeruloscler
osis
Focal
sclerotic
lesions
Membranous
Nephropathy
Thickened
GBM
Thickened
GBM,
proliferati
on
Granular IgG, C3
Membranoproli
ferative
Glomeruloneph
ritis
Type
I
Mesangial and
subendothelial
deposits
Management
Initial Episode
Subsequent course
Relapse
Infrequent Relapsers : 3 or less
relapses per year
Frequent Relapsers : 4 or more
relapses per year
Steroid therapy
Steroid dependant : relapse following
dose reduction or discontinuation
Steroid resistant : Partial or no
response to initial treatment
Management of Relapse
Parent Education
Symptomatic therapy for infections
in case of low grade proteinuria
Persistent proteinuria ( 3 - 4+ )
Prednisolone
( 2mg/kg/day until protein is negative
for 3 days )
1.5 mg/kg on alternate days for 4
weeks )
Frequent Relapses
Alternate Day prednisolone
Steroid sparing agents
Levamisole ( 2 2.5 mg/kg )
Cyclophosphamide ( 2 2.5 mg/kg/day)
Mycophenolate Mofetil ( 20 25
mg/kg/day )
Cyclosporin ( 4 5 mg/kg/day )
Tacrolimus (0.1 0.2 mg/kg/day )
Rituximab ( 375mg/m2 IV once a week )
Ghai Essential Paediatrics,8th edition, page
Complications
Edema
Infections
Thrombotic complications
Hypovolaemia and Acute renal
Failure
Steroid Toxicity
Management of SRNS
Steroids + calcineurin inhibitors + ACE
inhibitors / ARBs + HMG coenzyme-A
+ Diuretics
Prognosis
Steroid Responsive NS : Good
prognosis
( MCNS )
Steroid Resistant NS : Poor prognosis
( FSGS )
Congenital Nephrotic
Syndrome
Presents in first 3 months of life
Anasarca, hypoalbuminaemia, oliguria
Finnish Type Nephrotic Syndrome
Antenatally detectable :
Raised AFP in maternal serum and amniotic fluid
Complications
Failure o thrive
Infections
Hypothyroidism
Renal Failure ( 2 3 yrs )